Viewing Study NCT04997850


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-01-01 @ 3:17 PM
Study NCT ID: NCT04997850
Status: COMPLETED
Last Update Posted: 2025-08-29
First Post: 2021-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma
Sponsor: Xinrui Zhu,MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module